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INTRODUCTION
Environmental factors, especially food, have been
epidemiologically demonstrated to be closely associated
with human colorectal cancer (1-3). While complete
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Abstract : An 80% ethanol extract of Murdannia loriformis, a Thai medicinal plant, was
examined for antimutagenic activity and cancer chemopreventive activity. In the Salmonella
mutation assay, the extract showed antimutagenicity against 2-amino-3-methylimidazo
[4,5-f]quinoline, 2-amino-3,4-dimethylimidazo[4,5-f]quinoline, 2-amino-3,8-dimethylimidazo
[4,5-f]quinoxaline, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, 2-amino-1,4-dimethyl-
5H -pyrido[4,3-b]indole, 3-amino-1-methyl-5H-pyrido[4,3-b]indole, 2-amino-6-methyldipyrido
[1,2-a:3’,2’-d ] imidazole, 2-aminodipyrido[1,2-a:3’,2’-d ]imidazole, 2-aminoanthracene, 2-(2-
furyl)-3-(5-nitro-2-furyl) acrylamide,N-methyl-N’-nitro-N-nitrosoguanidineandmethylazoxymethanol
acetate and reduced their mutagenicities to 31.4～67.9% at the dose of 10 mg/plate. However,
it did not inhibit the mutagenicities of 2-amino-9H-pyrido[2,3-b]indole, 2-amino-3-methyl-9
H-pyrido[2,3-b]indole, benzo[a]pyrene, N-ethyl-N’-nitro-N-nitrosoguanidine and 1-nitropyrene.
The extract itself showed no mutagenicity. The chemopreventive activity of M. loriformis
was examined using azoxymethane (AOM)-induced aberrant crypt focus (ACF) formation
in the colon of F344 rats. The extract at doses of 0.1-1.0 g/kg wt significantly inhibited
ACF formation in the initiation stage (21 -51%), although it was more effective at a lower dose.
In the post-initiation stage, the extract also tended to inhibit ACF formation (12 -27%) and
significantly decreased the number of larger ACFs that have more than 3 aberrant crypts
per focus. The extract inhibited the formation of O6-methylguanine and N 7-methylguanine
in the colonic mucosa and muscular layers but not or increased in the liver. These results
indicate that M. loriformis extract has antimutagenic activity toward various known mutagens
and that it inhibits AOM-induced ACF formation both in the initiation and post-initiation
stages in the rat colon. J. Med. Invest. 49 : 25-34, 2002
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removal of causative agents of cancer may not always
be possible, chemoprevention of cancer using antimutagens
and anticarcinogens present in foods and in the
environment has been suggested to be most effective
method to prevent human cancer. Large numbers
of antimutagens and anticarcinogens exist in natural
products, especially in the plant kingdom (4). These
antimutagens and anticarcinogens may inhibit one
or more stages of carcinogenesis and prevent or delay
cancer development (5). Geographic variation in
colon cancer may also be attributable to differences
in consumption of protective factors in the diet such
as fiber, antioxidants and antiprolifelative agents.
Various kinds of Thai medicinal plants have been
shown to be antimutagenic and anticarcinogenic.
Lemon grass, for example, has been shown to be
antimutagenic against various mutagens (6) and to
inhibit azoxymethane (AOM)-induced DNA adduct
formation and aberrant crypt focus (ACF) formation
in the rat colon (7). Roselle and bitter melon have been
shown to inhibit colon carcinogen-inducedACF formation
in the rat colon (8, 9). TongTak (10),Acanthus ebracteatus
Vahl., Plumbago indica Linn. and Rhinacanthus nasuthus
Kurz. (11) have also been found to be antimutagenic.
Murdannia loriformis (Hassk.) Rolla Rao et Kammathy,
a Thai medicinal plant, is a traditional drug in Thailand
used for relief of bronchitis and cancer (12). Previous
studies have shown that M. loriformis extract inhibits
the mutagenicity of some kinds of mutagens in the
Salmonellamutation assay and induces DT-diaphorase
activity in a murine hepatoma cell line (Hepa 1c1c 7)
(13). In addition, an active glycosphingolipid isolated
fromM. loriformis exerted cytotoxicity against human
colon carcinoma and a human breast cancer cell line
(14). However, in vivo effects of M. loriformis extract
have not been reported.
ACFs are an early neoplastic lesions in the colonic
mucosa and were first observed in colon carcinogen-
treated mice and rats (15). They are morphologically
distinguishable from normal crypts by their larger
size and the more elliptical shape of the luminal
opening, with thicker lining of epithelial cells. These
lesions have also been observed in the human colon
(16). AOM is a typical colon carcinogen, and AOM-
induced ACFs in the rat colon have been used to
identify chemopreventive agents for colon cancer (17).
DNA adduct formation is also recognized as one of
the common properties of most potent carcinogens
and is the basis of current strategies in molecular
epidemiology and biomonitoring (18). AOM-induced
DNA adducts are N 7-methylguanine (N 7-meG) and
O 6-methyguanine(O 6-meG).N 7-MeG is quantitatively
the major alkylation product (19), but the level and
persistence ofO 6-meG in the target tissue ismore closely
correlated with the carcinogenicity (20).
In the present study, we investigated the inhibitory
effects ofM. loriformis extract on AOM-induced DNA
adduct formation and ACF formation in the rat colon.
MATERIALS AND METHODS
1) Chemicals
All heterocyclic amines (HCAs), including 2-amino-
3-methylimidazo[4,5-f]quinoline (IQ), 2-amino-3,4-
dimethylimidazo[4,5-b]quinoline (MeIQ), 3-amino-
3,8-dimethylimidazo[4,5-f ]quinoxaline (MeIQx), 2-
amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP),
2-amino-1,4-dimethyl-5H-pyrido[4,3-b]indole (Trp-P-1),
3-amino-1-methyl-5H-pyrido[4,3-b]indole (Trp-P-2),
2-amino-6-methyldipyrido[1,2-a:3’,2’ -d ]imidazole
(Glu-P-1), 2-aminodipyrido[1,2-a:3’,2’-d]imidazole (Glu-
P-2), 2-amino-9H-pyrido[2,3-b] indole (AαC), and 2-
amino-3-methyl-9H -pyrido[2,3-b] indole (MeAα C)
were kindly provided byDr.K.Wakabayashi, National
Cancer Center Research Institute.O 6-MeG was also
a generous gift from Drs. K. Ishizaki andM. Ikenaga,
Kyoto University. Aflatoxin B1 (AFB1), benzo[a]
pyrene (B[a]P), N-methyl-N’-nitro-N-nitrosoguanidine
(MNNG),N-ethyl-N’-nitro-N-nitrosoguanidine (ENNG),
methylazoxymethanol acetate (MAMacetate), AOM,
N 7-meG were purchased from Sigma Chemical Co.,
St. Louis,MO. 1-Nitropyrene (1-NP)was obtained from
Aldrich Chemical Co., Inc.,Milwaukee,Wis. 2-(2-Furyl)-
3-(5-nitro-2-furyl)acrylamide (AF-2), 2-aminoanthracene
(2-AA) and other chemicals, reagent grade or higher,
were fromWako Pure Chemical Industries, Ltd., Osaka,
Japan.
2) Extraction of Murdannia loriformis
M. loriformis was obtained from the garden at the
Research Institute for Health Science, Chiang Mai
University, Chiang Mai, Thailand. The whole fresh
plant was washed with tap water, cut into small pieces,
freeze-dried, and ground to a fine powder. The dry
powder (100 g) was extracted with 1 liter of 80%
ethanol for 24 h by stirring at room temperature.
Then the extarct was filtered through a paper filter
by suction, and the residue was extracted again
with 80% ethanol. The filtrates were combined and
evaporated to dryness in a rotary evaporator under
reduced pressure at 50℃. The dried residue was
used as M. loriformis extract that is abbreviated to
ML in Tables and Figures. The extract was weighed,
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dissolved in 25% dimethylsulfoxide (DMSO), and
kept at 4℃ until used. The yield of the extract was
0.12% from fresh plant and 1.2% from freeze-dried
powder of the plant. For the Salmonella mutation
assay, the extract was sterilized by filtration with a
disposable filter unit (cellulose acetate membrane,
pore size of 0.45 µm, Advantec) before being used.
3) Mutagenicity test
The mutagenicity and antimutagenicity of M.
loriformis extract were assayed using Salmonella
typhimurium strains TA98 and TA100 according
to the procedure of Maron and Ames (21) with the
modification of preincubation (22) in the presence
or absence of 9,000×g supernatant fraction (S9)
prepared from the liver of rats treated with drug-
metabolizing enzyme inducers, benzoflavone and
phenobarbital. The number of spontaneous revertants
was 24±6 in strain TA98 without S9, 37±10 in strain
TA98 with S9, 112±26 in strain TA100 without S9,
and 105±18 in strain TA100 with S9, and they were
subtracted in all data except for Table 1.
4) Animals
Four-week-old male F344 rats (80 - 100 g) were
purchased from SLC Japan (Hamamatsu, Japan).
Animals were housed in plastic cages with sawdust
bedding, maintained for 3 days and given food and
water ad libitum. The room in which the rats were
kept, in the Institute of Animal Experimentation,
The University of Tokushima School of Medicine,
was controlled at a temperature of 23±2℃, humid-
ity of 55±10%, and a 13-h light/11-h dark cycle.
5) Analysis of aberrant crypt foci
After quarantine for one week, rats were divided
into eight groups for ACF determination for the
initiation stage as shown in Fig.1 (a). Rats in groups 1
through 5 were subcutaneously injected with AOM
(15 mg/kg body weight) once a week for two weeks.
Groups 6, 7 and 8 were injected with saline as vehicle
controls. Groups 2, 3 and 4 were givenM. loriformis
extract (0.1, 0.5 or 1.0 g/kg body weight, respectively)
once a day by intragastric gavage. Groups 1 and 6
received 25% DMSO as control. Group 5 was given
1.0 g/kgM. loriformis extract for only 1 week and on
the next day they received the first AOM injection.
All of the rats were sacrificed by cervical dislocation
under anesthesia with lethal doses of diethyl ether.
The protocol for the post-initiation stage is shown
in Fig.1 (b). The rats were divided into six groups.
Two weeks after the second AOM injection, rats began
to be given M. loriformis extracts (1.0 or 0.1 g/kg
body weight) by intragastric gavage for 12 weeks.
Animals were carefully observed daily and weighed
weekly. The large intestines of sacrificed rats were
removed, expanded with 10% formalin in a phosphate
buffered saline solution (pH 7.4) on ice for 15 min,
and then cut open longitudinally along the main
axis. The intestines were cut into three portions :
the first is the rectum to 2 cm from the anus, and
the remaining colon was divided into two parts
called the proximal and distal colon. Then each
segment was placed between two pieces of filter
paper, fixed in 10% buffered formalin for 24 h, and
stained with 0.2% methylene blue in saline. ACF was
examined under a microscope at a magnification of
40×according to the procedure of Bird (15).
6) Analysis of DNA adducts
Rats were treated and sacrified 12 h after the second
AOM injection as described in Fig.1 (c). The perfused
liver and colon were immediately removed. The colon
was cut open longitudinally and washed with saline
to remove colonic contents. Then the colon was laid
flat on a glass plate and the mucosa was scraped off
with a glass slide. The livers, colonicmucosa andcolonic
muscle layers were kept at - 80℃ until analysis of DNA
adducts.
DNA was isolated by phenol extraction following
treatment with RNaset A, T1 and proteinase K (23).
The two step procedure for detection of DNA adducts
was based on the method of Beranek et al．(24)．Purified
DNA was dissolved in 10 mM sodium cacodylate
(pH 7.0）at the concentration of 5 mg/ml and was
subjected to neutral thermal hydrolysis by heating
at 100℃ for 30 min to release N 7-meG. The partially
apurinic DNAwas precipitated from the neutral thermal
hydrolysate by addition of 0.1 volume of cold 1 N
HCl and was collected by centrifugation at 3,000
Table 1. Mutagenicity test onM. loriformis extract
Dose
(mg/plate)
His+ revertants/plate
TA98 TA100
－S9 +S9 －S9 +S9
0
0.01
0.10
1.00
10.0
24
29
30
24
22
36
32
40
38
36
108
95
99
100
106
114
102
105
100
92
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(c) AOM-induced DNA adduct formation(a) AOM-induced ACF formation in the initiation stage
(b) AOM-induced ACF formation in the post-initiation stage
Figure 1. Experimental protocols for AOM-induced ACF formation in the initiation stage (a), in
the post-initiation stage (b) and AOM-induced DNA adduct formation (c). Rats were treated
with AOM andMurdannia loriformis extract as described in Materials and Methods.
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rpm for 20 min at 0℃. The pellet was suspended in
50 mM Bis-Tris-1 mMMgCl2 (pH 6.5) and completely
hydrolyzed in 0.1 volume of 1 N HCl at 70℃ for 30
min (acid hydrolysis). Methylated bases in neutral
thermal hydrolysates (N 7-meG) and acid hydrolysates
(O 6-meG) were analyzed by high-performance liquid
chromatography (HPLC) using a Chemcosorb 7-SCX
cation exchange column (4.6×250 mm, Chemco Scientific
Co., Ltd., Osaka, Japan) and 4mMammonium formate
(pH 3.0) as the mobile phase at a flow rate of 1.0ml/min.
Elution of the fluorescing base was monitored at
286 nm as an excitation wavelength and at 365 nm
as an emission wavelength. Authentic N 7-meG and
O 6-meG were used as standards.
7) Statistical analysis
The data were analyzed by one-way analysis of
variance.
RESULTS
1) Antimutagenicity of M. loriformis
M. loriformis extract was not mutagenic for Salmonella
typhimurium strains TA98 and TA100 in either the
presence or absence of S9 mix (Table 1). Antimutagenic
activities of the extract against various known mutagens
are shown in Table 2. The extract showed antimutagenicity
against tested heterocyclic amines, IQ, MeIQ, MeIQx,
PhIP, Trp-P-1, Trp-P-2, Glu-P-1 and Glu-P-2, in dose-
Table 2. Antimutagenicity effects of 80% ethanol extract ofM. loriformis on heterocyclic amines and known mutagens
His+ revertant/plate (% Mutagenicity)
Mutagen Dose
(µg/plate)
Strain S9 M. loriformis extract (mg/plate)
0 0.313 0.625 1.25 2.5 5.0 10.0
IQ
MeIQ
MeIQx
PhIP
Trp-P-1
Trp-P-2
Glu-P-1
Glu-P-2
AαC
MeAαC
AFB1
B[a]P
2-AA
AF-2
MNNG
ENNG
1-NP
MAM
0.004
0.0025
0.01
1.0
0.05
0.1
0.05
4.0
5.0
5.0
0.1
2.5
1.0
0.025
0.5
0.25
0.1
4.00*
TA98
TA98
TA98
TA98
TA98
TA98
TA98
TA98
TA98
TA98
TA98
TA100
TA98
TA98
TA100
TA100
TA98
TA100
+
+
+
+
+
+
+
+
+
+
+
+
+
－
－
－
－
－
882
(100)
1922
(100)
1293
(100)
1069
(100)
1523
(100)
1437
(100)
2407
(100)
1030
(100)
1244
(100)
816
(100)
1632
(100)
494
(100)
3626
(100)
1905
(100)
2646
(100)
455
(100)
546
(100)
668
(100)
811
(92.0)
1827
(95.0)
1446
(111.8)
1014
(94.8)
1339
(87.8)
1421
(98.9)
2149
(89.3)
854
(82.9)
1271
(102.2)
767
(94.0)
1592
(97.5)
591
(119.6)
2350
(64.8)
1327
(69.7)
2783
(105.2)
457
(100.4)
468
(85.7)
245
(36.7)
812
(92.1)
1826
(95.0)
1299
(100.5)
863
(80.7)
1434
(94.2)
1339
(93.2)
1978
(82.2)
905
(87.9)
1271
(102.2)
748
(91.7)
1653
(101.3)
591
(119.6)
2139
(59.0)
1354
(71.1)
2113
(79.8)
618
(135.8)
499
(91.4)
180
(26.9)
861
(97.7)
1717
(89.3)
1263
(97.7)
963
(90.1)
1368
(89.8)
1409
(98.0)
1769
(73.5)
829
(80.5)
1262
(101.4)
904
(110.8)
1686
(103.3)
548
(110.9)
2099
(57.9)
1256
(65.9)
2176
(82.2)
547
(120.2)
503
(92.2)
162
(24.2)
675
(76.5)
1628
(84.7)
1219
(94.3)
835
(78.1)
1357
(89.1)
1120
(77.9)
1683
(69.1)
866
(84.1)
1282
(103.0)
790
(96.8)
1707
(104.6)
489
( 99.0 )
2108
(58.1)
1245
(65.4)
1715
(64.8)
392
(86.1)
569
(104.2)
196
(29.3)
645
(73.1)
1349
(70.2)
994
(76.9)
845
(79.0)
1104
(72.5)
994
(69.2)
1557
(64.7)
540
(52.4)
1324
(106.4)
827
(101.3)
1756
(107.6)
417
(84.4)
2086
(57.5)
1300
(68.2)
1143
(43.2)
473
(103.9)
490
(89.8)
198
(29.6)
412
(46.7)
1076
(56.0)
842
(62.7)
613
(57.3)
941
(61.8)
734
(51.1)
914
(38.0)
365
(35.4)
1305
(104.9)
924
(113.2)
1364
(83.6)
477
(96.5)
1967
(52.3)
1294
(67.9)
1251
(47.3)
507
(111.4)
587
(107.5)
210
(31.4)
*mg/plate
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dependent manner except for Aα C and MeAα C.
About 40 - 60% of their mutagenicities was decreased at
10mg/plate. The extract also decreased themutagenicities
of 2-AA, AF-2, MNNG and MAM, and the mutagenicity
of MAM was decreased to 36.7% even at the lowest
dose (0.31 mg/plate). The extract had no effect on
the mutagenicities of B[a]P, ENNG and 1-NP.
2) Inhibitory effect of M. loriformis extract on
AOM-induced DNA methylation
The inhibitory effects of M. loriformis extract on
AOM-inducedDNAmethylation are shown in Table 3.
Methylated DNA adducts were not detected in the
solvent control group or in the extract treated-group.
The extract inhibited the formation of O 6-meG by
about 10 - 20% and 30 - 60% in the colonic mucosa and
muscular layers of the AOM-treated rats, respectively,
but not in a dose-dependent manner, and a significant
decrease was observed only in the muscular layers
of rats treated with AOM and 1.0 g/kg of the extract.
N 7-MeG was not decreased by continuous feeding.
Pretreatment at a dose of 1.0 g/kg for 1 week before
AOM administration was most effective, but the level
ofO 6-meG in the colonic mucosawas not significantly
lower than that in the AOM-treatedrats. In thepretreatment
group, the extract also significantly inhibited the
formation of N 7-meG both in the colonic mucosa and
muscular layer. Methylguanines in the liver tended
to be increased by the extract. The levels of O 6-meG
and N 7-meG in the liver of pretreatment group (group 4)
were increased by 2.2 and 1.5 fold, respectively, as
compared with those of the AOM-treated group.
3) Inhibitory effect of M. loriformis extract on AOM-
induced ACF formation
The body weights of rats in the control and M.
loriformis-treated groups were not significantly different
in either the initiation or the post-initiation stage
during the experiments. No abnormality was seen
with the naked eye in any group both in the initiation
and post-initiation stages. The effects ofM. loriformis
extract on AOM-induced ACF formation in the initia-
tion stage are shown in Table 4. Pretreatment with
the extract only for 1 week before AOM injection
at a dose of 1.0 g/kg most effectively inhibited the
ACF formation, and the number of ACFs significantly
Table 4. Inhibitory effect ofM. loriformis AOM-induced aberrant crypt foci in male F344 rats in the initiation stage
Treatment
Colon Rectum Total
n ACFb Crypt/focus ACF Crypt/focus ACF (% inhibition) Crypt/focus
25% DMSO+AOM
MLa1.0 g/kg wt+AOM
ML 0.５g/kg wt+AOM
ML 0.１g/kg wt+AOM
ML 1.0 g/kg wt (l wk)
+AOM
25% DMSO
ML 1.0 g/kg wt
ML 0.1 g/kg wt
8
6
7
8
8
6
6
6
115.4±29.6
94.2±25.2
75.8±36.6c
70.5±24.5c
48.9±13.6e
0±0f
0±0f
0±0f
1.32±0.11
1.28±0.09
1.33±0.12
1.31±0.08
1.27±0.11
0±0f
0±0f
0±0f
14.4±5.8
8.5±4.0c
10.1±2.8c
8.8±4.4c
8.2±2.3d
0±0f
0±0f
0±0f
1.49±0.41
1.08±0.10d
1.23±0.09c
1.23±0.19c
1.18±0.15c
0±0f
0±0f
0±0f
129.8±31.6(0)
102.7±27.4(20.9)
86.0±35.9d(33.8)
79.2±24.8c(39.0)
57.1±14.9r(56.0)
0±0f
0±0f
0±0f
1.35±0.15
1.27±0.09
1.32±0.11
1.30±0.08
1.25±0.11
0±0f
0±0f
0±0f
aMurdannia loriformis extract bMean number of ACFs/rat±SD cSignificantly different from 25% DMSO+AOM at p<0.05
dp<0.005 cp<0.0005 fp<0.0001
Table 3. Effects ofMurdannia loriformis extract on the levels of O６-methylguanine and N７-methylguanine in AOM-induced rats
Treatment
O6-Methylguanine (µmol/mol guanine)b N7-Methylguanine (mmol/mol guanine)
n Colonic mucosa Muscular layer Liver Colonic mucosa Muscular layer Liver
25% DMSO+AOM
MLa1.0 g/kg wt+AOM
ML 0.1 g/kg wt+AOM
ML 1.0 g/kg wt(l wk) +AOM
25% DMSO
ML 1.0 g/kg wt
ML 0.1 g/kg wt
5
5
5
5
4
4
3
91.4±27.2
79.2±12.4
82.8±18.1
73.0±14.6
<3.9±1.4g
<4.8±1.2g
<4.2±0.9g
41.0±30.9
16.8±9.3c
27.9±9.0
23.0±12.3
<5.9±4.3d
<3.9±0.5e
<4.1±1.6s
508.6±112.2
471.5±33.3
695.6±294.1
1119.1±239.4f
<5.4±0.9f
<5.9±0.8f
<4.6±1.3f
1.67±0.50
1.45±0.34
1.59±0.72
0.43±0.26f
<0.13±0.05f
<0.16±0.04f
<0.14±0.03f
1.69±0.75
1.85±1.11
1.13±0.22
0.29±0.21e
<0.20±0.14c
<0.13±0.02s
<0.14±0.05e
7.37±2.49
8.47±3.63
16.77±12.82c
10.80±5.13
<0.18±0.03g
<0.20±0.06g
<0.15±0.04g
aMurdannia loriformis extract bMean±SD cSignificantly different from 25% DMSO+AOM at p<0.05 dp<0.005 ep<0.001
fp<0.0005 gp<0.0001
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(p<0.0001) decreased to 44% of that in the positive
control group (25% DMSO+AOM). When the extract
was administered throughout the experimental period
at doses of 1.0, 0.5 and 0.1 g/kg, it inhibited ACF
formation by about 2１%, 34% and 39%, respectively.
The number of ACFs was significantly decreased only
at 0.5 g/kg wt (p<0.005) and at 0.1 g/kg wt(p<0.0005).
However, the extract was more effective at a lower
dose. Multiplicity of ACF (crypt/focus) was decreased
by M. loriformis treatment only in the rectum.
In the post-initiation stage, the extract did not
significantly decrease ACF formation either in the
colon or rectum (Table 5). However, it significantly
inhibited the formation of larger ACFs (more than
3 crypts/focus) by 27.0% in the total colon at 0.1 g/kg.
Multiplicity of ACF was significantly decreased by
treatment with the extract both at 0.1 and 1.0 g/kg.
4) Correlation between the number of ACFs and
DNA adduct level
A significant correlation between the number of
ACFs and the level ofO 6-meG in the colonic mucosa
was observed (r=0.808, p=0.0382, Fig.2), but not
between the number of ACFs and the level of N7-meG
in the colonic mucosa (data not shown).
DISCUSSION
Colorectal cancer has a high mortality rate in
Western countries and this may also soon be the
case in Asian countries because of rapidWesternization
of life style. However, the mortality rate of colorectal
cancer in Thailand is still low compared with that
in Japan (25, 26). This may be partially due to greater
consumption of spices, herbs and medicinal plants
in Thailand. Many kinds of chemical compounds
present in natural dietary products have been shown
to be protective against chemically induced toxicity
and carcinogenesis (4, 27-29). Some Thai medicinal
plants have been reported to be antimutagenic (6, 8 -11,
13) and to inhibit AOM-induced ACF formation in
the rat colon (7-9).M. loriformis is a Thai medicinal
plant that has been used for relief of bronchitis and
cancer (12). In the present study, we examined 80%
ethanol extract ofM. loriformis for its antimutagenic
activity and inhibitory effects on AOM-induced ACFs
formation.
Antimutagenicity ofM. loriformis against various
known mutagens was measured by the Salmonella
mutation assay in both strains TA98 and TA100 in
the presence or absence of S9 mix. The extract
inhibited the mutagenicity of tested heterocyclic
amines except for Aα C derivatives. These results
are similar to those of a previous report (13). SinceM.
loriformis inhibited almost all of the HCA-induced
mutations, it may possibly inhibit the metabolic
activation of HCAs by cytochrome P450 1A2. Factors
affecting the metabolic activation and DNA adduct
formation of HCAs were reviewed by Kato (30).
Unsaturated fatty acids such as oleic and linoleic
acids inhibited the mutagenicity of Trp-P-2 mainly
Table 5. Inhibitiory effects ofM. loriformis extract on AOM-induced aberrant crypt foci in male F344 rats in the post-initiation stage
Treatment
Colon Rectum Total
n ACFb Crypt/focus Multiple ACFc Focus Crypt/focus Multiple ACF Focus Crypt/focus Multiple ACF
25% DMSO+AOM
MLa1.0 g/kg wt+AOM
ML 0.1 g/kg wt+AOM
25% DMSO
ML 1.0 g/kg wt
ML 0.1 g/kg wt
10
5
7
6
4
5
257.4±65.6
236.0±38.3
223.0±35.6
0±0f
0±0f
0±0f
2.71±0.27
2.33±0.09e
2.35±0.25e
0±0f
0±0f
0±0f
52.1±12.2
43.2±8.3
38.3±11.9d
0±0f
0±0f
0±0f
57.4±23.0
51.6±11.1
45.8±11.0
0±0f
0±0f
0±0f
2.34±0.25
2.39±0.40
2.16±0.15
0±0f
0±0f
0±0f
7.8±3.5
9.4±6.6
5.4±4.2
0±0f
0±0f
0±0f
324.8±78.0
287.6±47.1
268.8±44.2
0±0r
0±0r
0±0r
2.64±0.26
2.34±0.11e
2.32±0.22d
0±0f
0±0f
0±0f
59.9±12.3
52.6±11.6
43.7±14.5d
0±0f
0±0f
0±0f
aM. loriformis extract bMean number of ACF/rat±SD cMultiple ACFs have more than 3 aberrant crypts/focus.
dSignificantly different from 25% DMSO+AOM at p<0.005 ep<0.001 fp<0.0001
Figure 2. Correlation between the number of ACFs/rat and
O 6-methylguanine levels in the rat colon. Correlation coefficients
were 0.808 in the colonic mucosa (p=0.0382) and 0.680 in the
muscular layer (p=0.0979).
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through the inhibition of hepatic mixed function
oxidase (31), and microsomal lipids or lecithin
diminished the amount of N -OH Trp-P-2 without
inhibiting the metabolism of Trp-P-2. Compound
lipids such as glycosphingolipid in M. loriformis possi-
bly inhibit P450 1A2-mediated activation or interact
with activated HCAs. Mutagenicity of methylating
agents was also inhibited, especially in the case of
MAM, whose mutagenicity was reduced by about 70%
with maximum inhibition at the lowest dose. The
interactions of some components of M. loriformis
with MAM or its ultimate form might contribute to
the decrease of mutagenicity.
SinceM. loriformis extract efficiently inhibited MAM-
induced mutation (Table 2), we examined whether
the extract inhibits AOM-induced DNAmethylation
and ACF formation in the rat colon. Formation of
ACF in the rat colon in the initiation stage was inhibited
by feeding rats the extract, while the formation of
O 6-meG in the rat colon was weakly inhibited byM.
loriformis treatment. Since the level of DNA adducts
correlated well with the number of ACFs in the colon
(Fig.2), inhibition of ACF formation was thought to
be partially due to the decrease in the level of adducts.
AOM was oxidatively metabolized to MAM by P
450 2E1 and transported to the colon via the blood
stream (32). Alternatively, MAM was conjugated
with glucuronic acid and transported via bile to
the colon (33). Conjugated MAM is hydrolyzed by
bacterial β-glucuronidase to free MAM in the intestine
(34), and released MAM is further metabolized and
methylates DNA in the colon (35). Although N 7-meG
is a major adduct,O 6-meG in the target tissue is more
closely correlated with carcinogenicity than is N 7-
meG because thymine can be incorporated opposite
O 6-meG resulting in GC→AT transition mutations
(19), and such alterations are frequently observed
in tumor-associated genes (36).
In the present study,M. loriformis extract inhibited
AOM-induced ACF formation partially due to the
decrease of O 6-meG level. Although mechanisms
of inhibition of DNA adducts formation by the ex-
tract are still unclear, current evidence suggests
that the components of M. loriformis can induce
chemoprotective enzymes such as glutathione S-
transferase, UDP-glucuronyl transferase and DT-
diaphorase (37). However, the level of bothO 6-meG
and N 7-meG in the liver were rather increased by
the extract. Modification of AOMmetabolism in the
liver and lowered distribution of the metabolites to
the colon might contribute to the decrease of O 6-
meG in the colon. Other possible mechanisms of
inhibition of ACF formation are enhanced DNA repair
or modification of cell proliferation as do curcumin
and other plant components (38).
The number of ACFs was more decreased at a
lower dose in the continuously fed group and most
strongly inhibited in the pretreatment group (Table 4).
It is not known why a lower dose was more effective
in inhibition of ACF formation.
In the post-initiation stage, multiplicity of ACF in
the total colon was significantly decreased by the
extract (Table 5). The number of ACFs that have more
than 3 crypts/focus, which is highly correlated with
tumor formation (17), was also significantly decreased.
These results suggest thatM. loriformis inhibits the
growth of ACFs. Recent studies have shown that die-
tary sphingolipids inhibit dimethylhydrazine-induced
colon cancer in CF1mice (39-41), presumably because
they are digested to the lipid backbones ceramide
and sphingosine that inhibit cell growth and induce
differentiation and apoptosis (42). Glycosphingolipids,
constituents ofM. loriformis, could contribute to the
inhibition of ACF formation by the above mechanisms.
We have investigated antimutagenicity of Thai
medicinal plants and their inhibitory effects on
AOM-induced ACF formation. Among tested plants,
M. loriformis and roselle (8) decreased themutagenicity
of heterocyclic amines such as PhIP and IQ, which
are colon carcinogens in rodents. Lemon grass was
the strongest inhibitor against the ACF formation in
the initiation stage by enhancing detoxification enzyme
activity (7). Inhibitory effect of M. loriformis on the
ACF formation was similar to those of roselle (8)
and bitter melon (9).
In conclusion, M. loriformis extract showed
antimutagenicity against various knownmutagens and
inhibited the formation of AOM-induced ACF and DNA
adduct formation in the rat colon. Chemopreventive
agents have been classified into three categories based
on the time period that the agents exert their inhibitory
activity in animal carcinogenesis models : inhibitors
of carcinogen formation, blocking agents that are
inhibitors of tumor initiation, and suppressing agents
that are inhibitors of tumor promotion and/or
progression (5).M. loriformis extract may act as ei-
ther a blocking or suppressing agent. However,
Yamada et al. (43) currently suggested that β-catenine-
accumulated crypts, which are independent of ACFs,
are truly premalignant lesions for colon cancer.
Usefulness ofM. loriformis extract for colon cancer
chemoprevention should be further investigated.
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